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Abstract: Neuronal connections through specialized junctions, known as synapses, create circuits
that underlie brain function. Synaptic plasticity, i.e., structural and functional changes to synapses,
occurs in response to neuronal activity and is a critical regulator of various nervous system functions,
including long-term memory formation. The discovery of mRNAs, miRNAs, ncRNAs, ribosomes,
translational repressors, and other RNA binding proteins in dendritic spines allows individual
synapses to alter their synaptic strength rapidly through regulation of local protein synthesis in
response to different physiological stimuli. In this review, we discuss our understanding of a number
of miRNAs, ncRNAs, and RNA binding proteins that are emerging as important regulators of synaptic
plasticity, which play a critical role in memory, learning, and diseases that arise when neuronal circuits
are impaired.
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1. Introduction
The mammalian brain is a complex structure, made up of millions of interlinked neuronal
circuits that form through synaptic connections. A fascinating property of the brain is its ability
to modify these neuronal circuits in response to various experiences such as learning new tasks,
stress, and drug abuse [1,2]. Synaptic plasticity refers to modifications that occur to alter the strength
of synaptic transmission at pre-existing synapses. Synaptic transmission can be either boosted or
depressed by activity and these alterations can be short-term, lasting from milliseconds to hours,
or long-term modifications that last for days to weeks or even longer [3–6]. Many mechanisms of
synaptic plasticity have been described, demonstrating the complexity associated with changes in
synaptic circuitry and transmission that constantly occur within the brain. Long-Term Potentiation
(LTP) and Long-Term Depression (LTD) are two forms of long-lasting plasticity, which have been
intensively investigated as models linked with memory and learning [3,4]. LTP is a form of plasticity
resulting in a persistent enhancement of synaptic transmission and is widely believed to be important in
memory formation, particularly in the hippocampal region of the brain which is involved in long-term
memory formation [7–10]. LTD is a contrasting process, in which the efficacy of synaptic transmission
is reduced [4].
↵-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMAPRs) are tetrameric
assemblies of glutamate-gated ion channels present on the post-synaptic membrane. AMPARs are the
major excitatory synaptic receptors in the brain and are tightly regulated to bring about changes in
synaptic strength [11]. LTP and LTD induction causes activation of N-Methyl-D-aspartate receptors
(NMDARs), which allows Ca2+ entry into the post-synapse. During LTP, a large influx of Ca2+ activates
calcium/calmodulin-dependent protein kinase II↵ (CaMKII↵). CaMKII↵ activates downstream
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signaling cascades that increase spine size and the number and sensitivity of AMPAR inserted in the
post-synaptic membrane [12–14] (Figure 1). In contrast, during LTD, a smaller influx of Ca2+ activates
the protein phosphatase-1 (PP-1) signaling pathway, which dephosphorylates AMPARs and promotes
their internalization to reduce post-synaptic surface receptors [15,16] (Figure 1). Furthermore, protein
synthesis is reduced which results in shrinkage of the dendritic spine and in some cases even complete
elimination of targeted spines [17].
Figure 1. Long-Term Depression (LTD) and Long-Term Potentiation (LTP). (A) LTD occurs when
a low rise in post-synaptic [Ca++] activates phosphatases that dephosphorylate AMPARs to reduce
their sensitivity and promote their endocytosis; (B) LTP occurs when a larger rise in post-synaptic
[Ca++] activates CaMKII, promotes AMPAR phosphorylation, and AMPAR insertion into the
post-synaptic membrane.
Over the last decade, microRNAs (miRNAs) have emerged as key regulators of synaptic
development and plasticity. miRNAs are an ever expanding class of small non-coding RNAs that
function in post-transcriptional gene expression, and to date hundreds have been identified that
are expressed in the brain [18–20]. miRNAs are transcribed by RNA polymerase II or III and are
subsequently cleaved by the Drosha and DGCR8 containing microprocessor complex in the nucleus.
The resulting pre-miRNA is exported to the cytosol and further processed by Dicer to an intermediate
miRNA duplex. The leading miRNA strand is loaded into the miRNA-induced silencing complex
(miRISC) and guided to target mRNAs to which it imperfectly pairs with sequences primarily in the
31 untranslated regions (UTRs) of the mRNA. This interaction leads to translational repression of the
target mRNAs and can be tightly regulated in neurons to control their rapid release and translation in
response to specific stimuli to modify synaptic plasticity [21]. The promiscuous binding of miRNAs
to target mRNAs allows a single class of miRNAs to repress multiple target transcripts involved in
specific processes, which is an important feature for inducing synaptic plasticity by regulating local
translation of dendritic transcripts during synaptic stimulation [22]. In this review, we discuss the
importance of miRNAs and RNA binding proteins (RBPs) in synaptic plasticity and how they are able
to rapidly induce synaptic changes by altering localized mRNA translation.
2. Dendritic Protein Synthesis
mRNA translation occurs in a compartmentalized manner within neurons to allow proteins to be
synthesized locally to their sites of function [23]. Even within individual dendritic spines, synaptic
proteins are translated at discrete sites to rapidly provide new proteins for synapses that require
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them [24]. Dendritic protein synthesis is regulated by a number of key factors, including miRNAs,
RBPs and polyribosomes, which allow dendrites to undergo rapid synaptic plasticity in response to
various synaptic stimuli.
Early studies identified polyribosomes within dendritic shafts and at the base of spines in
neuronal cultures under basal conditions [25]. After intense synaptic activity, polyribosomes and
translational initiation factors were observed to migrate into dendritic spines and localize at the
postsynaptic density (PSD) of synapses [26–29]. PSDs are protein dense regions containing cytoplasmic
proteins, membranous receptor proteins and receptor scaffold proteins underlying the postsynaptic
membrane [30]. The re-localization of the protein synthesis machinery towards PSDs after intense
synaptic activity implies neurons are capable of remodeling their synapses locally by translating
new proteins.
Several studies have identified molecular mechanisms underlying mRNA transport from the cell
body to dendritic spines. This process normally involves RNA species bound to RBPs as single mRNP
complexes or present in clusters within RNA granules to be attached to microtubule-based motor
proteins [31–36]. Originally, only a small number of mRNA species were thought to be transported to
neuronal dendrites, but with advances in RNA sequencing techniques hundreds of different mRNAs
have now been identified which are translated in an activity-dependent manner [22,37]. This includes
transcripts for proteins extensively characterized to be involved in synaptic plasticity, for example,
fragile X mental retardation protein (FMRP), AMPAR subunits GluR1/2, CaMKII↵, and LIM domain
kinase 1 (LIMK1) [38–41].
Regulating protein synthesis in dendrites supports long-term changes in the growth and
branching of spines, thus playing an important role in LTP, and in cognitive processes such as
memory and learning [42–45]. For example, Fragile X syndrome (FXS) is the most common genetic
disorder of intellectual disability worldwide. In FXS, the translational repressor protein, FMRP,
is not expressed [46,47]. FMRP is a translational repressor which binds to ~4% of brain mRNAs
and is particularly important in influencing synaptic plasticity. In FXS cells, neuronal protein
synthesis is hyperactive under basal conditions, which disrupts dendritic morphology and synaptic
strength [48–51]. Attempts to normalize protein synthesis levels in mouse models of FXS have proven
successful in restoring behavioral deficits, suggesting that the translational machinery in neurons may
represent novel therapeutic targets for memory and learning disorders [49,52,53].
3. Dendiritc miRNAs
By exploiting miRNAs and RBPs involved in miRNA-mediated translational repression, neurons
are well equipped to dynamically alter their proteomic profile in a localized manner. Here we discuss
how some important miRNAs behave in an activity dependent manner to govern localized protein
synthesis in dendrites and at synapses to influence synaptic plasticity (Figure 2, Table 1).
Table 1. miRNAs involved in synaptic plasticity. miRNAs are important regulators of neuronal
translation in the soma and within dendritic spines and synapses. This table summarizes key
miRNAs identified within neuronal dendrites that have been identified to be major regulators in
synaptic plasticity.
miRNA Target Refs.
miR-134 LIMK1, Pum2 [40,54]
miR-132 p250GAP [55]
miR-125b NR2A [56]
miR-191 Complexin-1, Complexin-2 [37]
miR-135a TPM2 [37]
miR-501-3p Gria1 [57]
miR-138 APT1 [58]
miR-188 NRP2 [59]
miR-124 Gria2 [60]
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Figure 2. miRNAs involved in aclivity dependent AMPAR trafficking and dendritic structural plasticity.
(A) miRNAs involved in NMDA-mediated AMAPR expression and trafficking. In response to NMDA,
miR-501-3p is upregulated resulting in GluAl suppression and miR-135a is downregulated causing an
increase in complexin-1/-2 levels and resulting in reduced AMAPR exocytosis; (B) miRNAs involved
in dendritic structural plasticity miR-134 actrvity is enhanced in response to NMDA, resulting in
downregulation of LIMK1 and activation of the actin depolymerizer, cofilin. Furthermore, expression
of miR-132 and miR-191 increase, resulting in suppression of Rho signaling and Tropomodulin-2
(TPM2) respectively, thus repressing actin polymerization.
3.1. miR-134
The actin cytoskeleton is essential for structurally re-modelling spines, and its dynamic
rearrangement induced by synaptic activity are essential for this [61,62]. In response to LTD,
filamentous actin (F-actin) in spines depolymerizes (Figure 2). Activation of the F-actin depolymerizing
protein, cofilin, and inhibition of the actin polymerization complex, Arp2/3, are fundamental signalling
cascades underlying actin reorganization for spine shrinkage in LTD [63,64].
miR-134 is a brain specific miRNA, embedded within the mammalian specific miRNA cluster
(miR379-410). Schratt et al. demonstrated miR-134 is enriched in neuronal dendrites of hippocampal
neurons, where it targets the LIMK1 transcript [40]. Limk1 controls spine structure by regulating actin
filament polymerization through binding to and inhibiting cofilin [65]. miR-134 mediated translational
repression of Limk1 negatively regulates spine size and during cLTD enhanced miR-134 activity and a
reduction in Limk1 has been observed, supporting its role in activity dependent spine re-modeling [66].
Further studies demonstrate miR-134, together with other miR379–410 members, is required
for activity-dependent dendritogenesis in rat hippocampal neurons by fine-tuning Pumilio2 (Pum2)
protein levels [54]. Pum2 is an RBP involved in translational repression and its regulation by miR-134
is key in activity-dependent plasticity [54]. Pum2-mediated miR134 repression illustrates a regulatory
pathway that couples activity-dependent transcription ofmiRNAwithmiRNA-dependent translational
control of gene expression in neuronal development, suggesting a possible cascade that might alter
levels of multiple downstream effector genes.
In vivo experiments have provided a great tool for identifying the importance of miRNAs
in memory formation and disease. Sirtuin-1 (SIRT1) is a nicotinamide adenine dinucleotide
(NAD+)-dependent deacylase that has been linked with genome stability in neurons [67]. SIRT1
has been identified to modulate synaptic plasticity and memory formation by repressing miR-134
expression [68]. In the absence of SIRT1, increased activity of miR-134 caused down regulation of the
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transcription factor cAMP response element-binding protein (CREB), resulting in impaired synaptic
plasticity. Additional in vivo studies have identified a functional role for miR-134 in specific periods of
neuronal development and miR-134 has also been shown to play a role in neuroprotection and seizure
suppression effects in mice [69].
3.2. miR-132
The neuronal enriched miR-132 was identified through a genome-wide screen as a CREB
target [70]. Like many neuronal CREB targets, miR-132 is induced by neuronal activity and
neurotrophins and plays a role in regulating neuronal morphology and excitability [71]. In cortical
neuronal cultures, up regulation of miR-132 increases dendritic outgrowth in an activity-dependent
manner by repressing GTPase-activating protein p250GAP translation, resulting in increased activation
of the Rac1-PAK actin-remodeling pathway (Figure 2). In contrast, miR-132 inhibition attenuates
neuronal outgrowth [55]. Furthermore, an additional study has demonstrated over expression of
miR-132 in hippocampal neurons resulting in stubby and mushroom-shaped spines with an increase
in protrusion size strengthening synaptic transmission [56]. miR-132 knockout mice additionally
supported these findings, with their hippocampal neurons displaying reduced dendrite length,
arborization, and spine density [72]. Together these studies support a role for miR-132 in regulating
dendritic spine structures and synaptic transmission.
The tight regulation and fine-tuning of miR-132 expression is an important aspect of creating and
controlling neuronal circuits. miR-132 was identified to be upregulated in the mouse hippocampus
after presentation of spatial learning tasks [73]. Interestingly, miR-132 expression is downregulated
in schizophrenia, with several miR-132 targets (DNMT3A, GATA2, and DPYSL3) displaying altered
expression in tissue from adult schizophrenic subjects [74,75]. These experiments highlight the
importance of buffering miR-132 levels over a fine concentration range for learning and memory
formation and show the important roles miRNA fine tuning plays to regulate its downstream
target genes.
Overall, studies on miR-134 and miR-132 demonstrate how complementary work in vitro and
in vivo provides a powerful approach to dissecting the complex role miRNAs play during synaptic
plasticity. These studies illustrate how miRNAs regulate multiple target genes at various stages in
development to control both developmental and physiological plasticity.
3.3. Other miRNAs
miRNA regulation at the synapse is not only negative, for example, miR-125b mediates positive
regulation of dendritic spine development [56]. miR-125b and several other miRNAs are associated
with FMRP in mouse brain. miR-125b overexpression in hippocampal neurons results in longer,
thinner dendrites and FMRP knockdown enhances the effect of miR-125b overexpression on spine
morphology [56]. A mechanism has been proposed whereby FMRP phosphorylation provides a
reversible switch in which Ago2 and miR-125a silence PSD-95 transcript. PSD-95 is key scaffold for
positioning AMPARs in the post-synaptic membrane. During LTD, AMPARs are released from PSD-95,
allowing them to laterally diffuse away from the synapse and be endocytosed [76]. Dephosphorylation
of FMRP and the subsequent release of Ago2 from the PSD-95 mRNA, increases PSD-95 levels in the
synapse and results in activation of mGluR signaling [77]. This switching mechanism could provide the
means for temporal and spatial control of translation in response to post-synaptic receptor activation.
Recently, Hu et al. used next-generation deep sequencing to identify miRNAs differentially
expressed in hippocampal neurons in response to chemically induced LTD (cLTD) [37]. They identified
a substantial change in the miRNA transcriptome, with 34 upregulated and 36 downregulated
miRNAs following cLTD. Enrichment analysis demonstrated many of these miRNAs induced changes
in expression of target transcripts for proteins involved in synaptic transmission, actin-dependent
processes, cytoskeletal binding proteins, and protein kinases and phosphotases, supporting previous
work demonstrating that miRNAs play roles in the structural and functional plasticity of synapses [37].
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Hu et al. studied the effects of miR-191 and miR-135a, which are downregulated and upregulated in
response to cLTD, respectively. miR-135a represses tropomodulin-2, which is an actin filament-pointed
end-capping protein that regulates the dynamics, length and amount of actin filaments [78].
They demonstrated that upregulation of miR-135a in response to cLTD is required to maintain reduced
levels of F-actin beyond initial spine shrinkage and that this is important for long-lasting spine
remodelling [37] (Figure 2). Hu et al. identified miR-191 to target complexin-1 and -2, which have a
highly similar sequence. Both complexins are components of the SNARE complex involved in AMPAR
exocytosis, and therefore important for inducing surface levels of AMAPRs for LTP [79,80]. Hu et al.
identified that to maintain spine shrinkage during LTD, AMPAR exocytosis has to be inhibited by
miR-135a translational repression of both complexins-1 and -2 [37] (Figure 2). In summary, this study
demonstrated that expression changes of miR-191 andmiR-135 after cLTD are required for maintenance
but not induction of spine restructuring. Furthermore, actin depolymerization and AMPAR trafficking
are regulated for extensive periods of time by miR-135a and miR-191 to support long-lasting spine
plasticity [37].
In an additional study, the same authors performed miRNA pull-down experiments and
computational prediction analysis to identify miR-501-3p as a target for the 31 UTR of the transcript
encoding AMPAR subunit GluA1 [57]. miR-501-3p was shown to increase locally in dendrites
after NMDAR activation and this upregulation of miR-501-3p is required for NMDAR-dependent
inhibition of GluA1 expression, long-lasting spine shrinkage, and elimination (Figure 2). Furthermore,
the expression of miR-501-3p and GluA1 is inversely correlated during postnatal brain development.
Together, these two studies by Hu et al. not only demonstrate the importance of miRNAs in
activity-dependent local synthesis of dendritic AMPARs, but also their trafficking pathways.
4. Other Non-Coding RNAs (ncRNAs) in Synaptic Plasticity
As well as miRNAs, additional classes of ncRNAs such as Long non-coding RNA (lncRNA),
piwi-RNAs, and circular RNA (circRNA) have been identified to be important in regulating protein
synthesis in dendrites. In this section, we briefly describe how the long non-coding RNA BC1/BC200
and circRNAs add an additional layer of complexity associated with protein synthesis in dendrites
and synapses during plasticity.
4.1. Long Non-Coding RNAs
Long non-coding RNAs (lncRNAs) are non-protein coding transcripts that are longer than
200 base-pairs and, unlike miRNAs, have a low conservation between species [81,82]. lncRNAs
are transcribed from various regions of the genome which include “gene desserts” between protein
coding genes as well as regions which overlap two or more protein coding genes. Furthermore,
they can be transcribed in both a sense and anti-sense manner allowing tens of thousands of lncRNAs
to be transcribed [83,84]. The human genome contains ~25,000 protein coding genes and up to
20,000 lncRNAs are predicted to be expressed in the brain which suggests many lncRNAs are likely
to have fundamental roles in brain function, including memory and learning [85]. Although not
limited to, lncRNAs have been identified to function as “molecular sponges” for miRNAs and RBPs,
while others provide platforms for assembling translational repression/activation mRNP complexes
by binding to specific recognition motifs on mRNAs [82]. The function of lncRNAs is ever expanding,
with new functional roles for different lncRNAs constantly emerging.
BC1/BC200 was one of the first lncRNAs to be studied and is the only example to date of a
lncRNA that regulates translation in neurons [86]. BC1/BC200 regulates synaptogenesis and is present
in neuronal dendrites where it interacts with FMRP and components of the translational machinery to
control 48S complex formation and repress local translation in synapses [87,88]. BC1/200 expression
is reduced at synapses when neuronal activity is blocked and is therefore recognized as a putative
plasticity gene that alters the proteome of synapses in response to neuronal activity [89]. Increased
neuronal activity in a particular dendritic region would enhance local expression of BC1/200 and
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negatively feedback on the rate of local translation. BC1/BC200 knock-out mice have uncontrolled
group I mGluR-stimulated synaptic protein synthesis, which results in excessive neuronal excitation
causing convulsive seizures, anxiety, and behavioral defects [90–92]. Therefore translational control
mediated by BC1/200 is an essential neuronal plasticity mechanism that regulates neuronal activity
and behavior.
4.2. Circular RNAs
Circular RNAs (circRNAs) are RNA species that form when the 51 end of one exon and the 31 end
of another are covalently linked. Although the function of this class of ncRNA is not entirely clear, it is
believed they play a role in post-transcriptional regulation [93,94]. For example, an elegant study by
Memczak et al. demonstrated that human circRNA, antisense to the cerebellar degeneration-related
protein 1 transcript (CDR1as), contains 63 binding sites for miR-7 [93]. CDR1 has a ~10 fold greater
affinity to miR-7 than any other transcript and is able to act as a molecular “sponge” to sequester miR-7
suppressing other mRNAs. Interestingly, CDR1 is enriched in the brain, and when human CDR1as
was expressed in zebrafish, it mimicked miR-7 knockdown by impairing midbrain development [93].
More recently, deep RNA profiling identified ~13,000 unique circRNA from five different
tissues [95]. circRNAs were particularly enriched in the brain relative to other tissues and interestingly
many were transcribed from genes encoding synaptic proteins. In some cases, circRNAs were more
enriched in dendrites than their linear variants demonstrating expression of circRNAs are unlikely
to be linked to expression of protein coding genes [95]. Furthermore, their expression was regulated
throughout development and in response to neuronal activity, suggesting they are important for both
synaptogenesis and plasticity. For example, when homeostatic plasticity was induced by treating
hippocampal neurons with the GABAA receptor antagonist bicuculline, circHomer1_a (derived from the
Homer1 gene) levels were elevated ~5.5 foldwhereasHomer1amRNA levels only increased ~1.5 fold [95].
Homer1 plays a major role in the organization of PSDs and is important in mGluR signaling, suggesting
GABAA signaling could influence mGluR signaling via a circRNA-mediated mechanism [96–98].
A key finding from this study suggested brain circRNAs are unlikely to serve as “molecular
sponges” for miRNAs or RBPs [95]. This indicates brain circRNAs are likely to be involved in synaptic
plasticity and synaptogenesis via a diverse set of new biological mechanisms that have yet to be
identified. This study opens doors for future research where specific circRNAs can be overexpressed
or depleted from neurons both in vivo and in vitro to identify their functions in brain development,
disease, memory, and learning.
5. RNA Binding Proteins and Synaptic Plasticity
RNA granules are large assemblies of aggregated RNA-protein complexes that contain silent
mRNAs in association with translational repressors, miRNAs, and/or specific RBPs. RNA granules
are both highly heterogeneous in structure, protein, and RNA compositions, and highly dynamic as
their dissolution correlates with translational activation [35]. mRNA Processing-bodies (P-bodies/PBs)
are the best characterized RNA granules and are present in virtually all cell lines and model organisms
studied. However, PBs in neuronal dendrites and synapses are different from PBs in non-neuronal
cell lines, with several studies reporting that individual PBs within neurons can contain different
protein compositions [99–101]. Interestingly, dendritic PBs respond to neuronal activity, for example,
NMDAR stimulation induces the dissolution of a specific sub-type of PBs that contain the Decapping
Co-activator Protein 1a (DCP1a), putatively releasing transcripts to allow their translation [99].
Recently, S-foci have been identified as a similar class of neuronal specific RNA granules that behave in
a similar fashion [102]. S-foci contain the translational repressor Smaug1/Samd4a and associate to the
post-synapse. Just like neuronal PBs, S-foci dissolve upon NMDAR activation. The CamKIIa transcript
was identified to be repressed in S-foci, and dissolution of S-foci correlates with increased translation of
CamKII↵, suggesting RNA granules can carry transcripts for proteins important in synaptic plasticity,
but more importantly play a role in regulating their translation [102,103].
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Cytoskeletal remodeling in dendritic spines and at synapses is an important aspect of synaptic
plasticity in LTP and LTD.  -actin mRNA and the Zip code Binding Protein 1 (ZBP1) have recently
been shown to localize within dendritic granules under a masked state using single-molecule in situ
hybridization [104]. Upon chemically-induced LTP,  -actin transcripts are released along with
ribosomes to increase dendritic  -actin synthesis. Theoretically, numerous additional transcripts
could go through similar masking/unmasking phases determined by neuronal activity and involving
specific RBPs including FMRP, Pumilio, and several PB components.
Further studies still need to dissect the mechanisms that underlie RNA granule disassembly in
response to neuronal activation. So far, the disassembly of S-foci upon NMDAR stimulation has been
shown to occur in response to elevated localized Ca2+ levels and the activation of the PI3K/mTOR
pathway [103]. However, the downstream mechanism other RNA granules use within dendrites
to disassemble or modify their structures and compositions in response to synaptic stimulation
has yet to be determined. These signaling cascades could potentially affect the way mRNPs within
granules aggregate with direct consequences in granule organization and translational repression. RNA
granules are associated with the cytoskeleton, and previous studies demonstrate the importance of
the cytoskeleton in the dynamic properties of RNA granules [105]. Therefore, cytoskeletal remodeling
that occurs during synaptic plasticity could participate in promoting granule dissolution or assembly,
thus controlling translation or repression of certain proteins respectively.
6. Summary
Over the last decade, clear examples exist where ncRNAs and RBPs play a fundamental role in
controlling synaptic plasticity. Certain miRNAs, such as miR-134 and -132, have been extensively
studied and could provide good therapeutic targets for treating cognitive disorders. However, a large
list of neuronal miRNAs, but particularly lncRNA and circRNAs, exist which have unidentified
functions. Future work should focus on identifying their targets and elucidating how they are
regulated in an activity dependent manner to regulate synaptic plasticity. Likewise, the function
of multiple RBPs and their targets remain a mystery, particularly those localizing within granules.
Additionally, the heterogeneous nature of neuronal granules may exist to allow different transcripts to
be regulated in response to different stimuli and provide an additional layer of control in regulating
synaptic plasticity.
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